Glucocorticoids Act Directly on Osteoblasts and Osteocytes to Induce Their Apoptosis and Reduce Bone Formation and Strength
Central Arkansas Veterans Healthcare System · University of Arkansas for Medical Sciences
Abstract
Whether the negative impact of excess glucocorticoids on the skeleton is due to direct effects on bone cells, indirect effects on extraskeletal tissues, or both is unknown. To determine the contribution of direct effects of glucocorticoids on osteoblastic/osteocytic cells in vivo, we blocked glucocorticoid action on these cells via transgenic expression of 11beta-hydroxysteroid dehydrogenase type 2, an enzyme that inactivates glucocorticoids. Osteoblast/osteocyte-specific expression was achieved by insertion of the 11beta-hydroxysteroid dehydrogenase type 2 cDNA downstream from the osteoblast-specific osteocalcin promoter. The transgene did not affect normal bone development or turnover as demonstrated by…
Citation impact
- FWCI
- 6.75
- Percentile
- 100%
- References
- 33
Authors
8- CACharles A. O’BrienCorresponding
Central Arkansas Veterans Healthcare System, University of Arkansas for Medical Sciences
- DJDan Jia
University of Arkansas for Medical Sciences
- LILilian I. Plotkin
University of Arkansas for Medical Sciences
- TBTeresita Bellido
University of Arkansas for Medical Sciences
- CCCara C. Powers
University of Arkansas for Medical Sciences
Topics & keywords
- Osteocyte
- Internal medicine
- Endocrinology
- Osteoblast
- Glucocorticoid
- Genetically modified mouse
- Transgene
- Osteocalcin